TipRanks
Aubex Corporation (JP:3583)
:3583
Japanese Market
Want to see JP:3583 full AI Analyst Report?

Aubex Corporation (3583) AI Stock Analysis

0 Followers

Top Page

JP:3583

Aubex Corporation

(3583)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - Gpt-5.6Sol)
Rating:64Neutral
Price Target:
¥1,455.00
▲(14.12% Upside)
Action:Reiterated
Date:10/10/26
The score is driven primarily by mixed financial performance: strong and improving leverage is offset by a steep 2026 revenue drop and weak/volatile cash generation including negative free cash flow. Support comes from attractive valuation (low P/E and a moderate dividend yield) and a mildly positive technical backdrop with neutral momentum.
Positive Factors
Improving Balance Sheet
The sustained reduction in leverage gives Aubex greater financial flexibility and lowers balance-sheet risk. A conservative capital structure can help the company withstand operating volatility, preserve borrowing capacity, and fund necessary investment without excessive dependence on external financing.
Negative Factors
Sharp Revenue Contraction
The steep 2026 revenue decline is a major threat to Aubex’s earnings durability because a smaller sales base can reduce operating leverage and weaken asset productivity. Sustained contraction would make it harder to preserve margins, reinvest, and maintain consistent profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Balance Sheet
The sustained reduction in leverage gives Aubex greater financial flexibility and lowers balance-sheet risk. A conservative capital structure can help the company withstand operating volatility, preserve borrowing capacity, and fund necessary investment without excessive dependence on external financing.
Read all positive factors

Aubex Corporation (3583) vs. iShares MSCI Japan ETF (EWJ)

Aubex Corporation Business Overview & Revenue Model

Company Description
AuBEX CORPORATION is a global manufacturer and distributor, focusing on precision nibs and essential medical equipment. The company's nibs are meticulously crafted from diverse materials such as polyester, nylon, acrylic, and various types of plas...

Aubex Corporation Financial Statement Overview

Summary
Balance sheet strength is a clear positive (debt-to-equity improved to ~0.21 by 2026), but operating results are pressured by a sharp 2026 revenue decline (~-49% YoY) and margin compression. Cash flow is the biggest weakness, with volatile conversion and negative free cash flow in 2026.
Income Statement
56
Neutral
Balance Sheet
74
Positive
Cash Flow
42
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.98B6.01B6.04B5.39B5.32B5.49B
Gross Profit2.02B2.01B2.26B1.84B1.84B1.92B
EBITDA941.05M906.55M1.13B831.11M914.89M991.05M
Net Income465.14M573.00M580.14M436.44M469.19M536.51M
Balance Sheet
Total Assets10.32B10.17B9.89B9.76B9.35B9.48B
Cash, Cash Equivalents and Short-Term Investments2.83B2.63B2.85B2.95B2.48B2.50B
Total Debt1.58B1.52B1.49B1.84B2.20B2.33B
Total Liabilities3.04B2.91B3.18B3.50B3.51B4.07B
Stockholders Equity7.28B7.25B6.71B6.26B5.83B5.42B
Cash Flow
Free Cash Flow0.00-109.94M464.72M911.79M68.05M836.70M
Operating Cash Flow0.00329.18M637.43M1.05B338.31M1.00B
Investing Cash Flow0.00-443.82M-159.74M-164.65M-183.55M-189.45M
Financing Cash Flow0.00-148.61M-561.99M-450.60M-205.90M-265.57M

Aubex Corporation Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1275.00
Price Trends
50DMA
1339.66
Negative
100DMA
1291.99
Positive
200DMA
1289.73
Positive
Market Momentum
MACD
0.89
Positive
RSI
45.79
Neutral
STOCH
79.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3583, the sentiment is Negative. The current price of 1275 is below the 20-day moving average (MA) of 1353.25, below the 50-day MA of 1339.66, and below the 200-day MA of 1289.73, indicating a neutral trend. The MACD of 0.89 indicates Positive momentum. The RSI at 45.79 is Neutral, neither overbought nor oversold. The STOCH value of 79.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3583.

Aubex Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
¥3.69B7.84―2.63%-1.01%-24.03%
58
Neutral
¥2.11B23.72―2.51%3.89%17.15%
57
Neutral
¥32.08B-185.75―3.29%-0.24%92.09%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
¥1.93B29.23―1.71%-0.91%-64.92%
52
Neutral
¥4.19B10.76―1.64%-3.00%-59.11%
46
Neutral
¥6.44B419.94―1.83%0.24%―
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3583
Aubex Corporation
1,333.00
70.03
5.54%
JP:4558
Chukyo Iyakuhin Co., Ltd.
199.00
-0.96
-0.48%
JP:7506
HOUSE OF ROSE Co.,Ltd.
1,369.00
5.66
0.42%
JP:7601
POPLAR Co., Ltd.
164.00
-16.00
-8.89%
JP:8217
Okuwa Co., Ltd.
791.00
-47.01
-5.61%
JP:8260
Izutsuya Co., Ltd.
366.00
-54.10
-12.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2026